Literature DB >> 3792769

Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity.

R L Edwards, J B Levine, R Green, M Duffy, E Mathews, W Brande, F R Rickles.   

Abstract

We have examined the relationships among activation of blood coagulation, generation of monocyte procoagulant activity, and clinical activity in patients with Crohn's disease. Subclinical activation of blood coagulation was measured using a radioimmunoassay for fibrinopeptide A. Fibrinopeptide A levels were strongly correlated with the level of disease activity as measured by the Crohn's disease activity index. Patients with active disease who were successfully treated either medically or surgically demonstrated a reduction of fibrinopeptide A levels. Failure of fibrinopeptide A to return to the normal range predicted an early relapse. Monocyte tissue factor generation was assessed in both unstimulated and lipopolysaccharide-stimulated mononuclear cell cultures obtained from the peripheral blood of patients with Crohn's disease. A strong correlation (r = 0.89) was observed between plasma fibrinopeptide A levels and monocyte tissue factor generation. These results suggest that monocyte procoagulant generation may contribute to the activation of blood coagulation in this inflammatory bowel disease. Moreover, fibrinopeptide A levels in Crohn's disease may provide a useful quantitative measure of inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3792769

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  24 in total

1.  Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.

Authors:  R K Linskens; A A van Bodegraven; M Schoorl; H A Tuynman; P Bartels
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Circulating cell-derived microparticles in Crohn's disease.

Authors:  Patrick Chamouard; Dominique Desprez; Bénédicte Hugel; Corinne Kunzelmann; Carole Gidon-Jeangirard; Michel Lessard; René Baumann; Jean-Marie Freyssinet; Lélia Grunebaum
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

3.  Elevated plasma cryofibrinogen in patients with active inflammatory bowel disease is morbigenous.

Authors:  Koji Sawada; Ryouki Takahashi; Abbi R Saniabadi; Maiko Ohdo; Takashi Shimoyama
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 4.  Smoking, the oral contraceptive pill, and Crohn's disease.

Authors:  A J Wakefield; A M Sawyerr; M Hudson; A P Dhillon; R E Pounder
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

Review 5.  Procoagulant activity in gastroenterology.

Authors:  A Wakefield; Z Cohen; G Levy
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

6.  Activation of plasma contact and coagulation systems and neutrophils in the active phase of ulcerative colitis.

Authors:  A Stadnicki; M Gonciarz; T J Niewiarowski; J Hartleb; M Rudnicki; N B Merrell; R A Dela Cadena; R W Colman
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

Review 7.  Mononuclear phagocytes.

Authors:  M J Auger
Journal:  BMJ       Date:  1989-03-04

8.  Postoperative portal and splenic vein thrombosis in children: identification of risk factors.

Authors:  Tadao Okada; Fumiaki Sasaki; Nozomi Minagawa; Satsuki Naito; Ryouji Kobayashi; Mitsuru Kubota; Satoru Todo
Journal:  Pediatr Surg Int       Date:  2005-11       Impact factor: 1.827

9.  Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease.

Authors:  L More; R Sim; M Hudson; A P Dhillon; R Pounder; A J Wakefield
Journal:  J Clin Pathol       Date:  1993-08       Impact factor: 3.411

10.  Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease.

Authors:  J C Souto; E Martínez; M Roca; J Mateo; J Pujol; D González; J Fontcuberta
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.